Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
45 people get JGBO articles and Market Currents by email alert.
Get email alerts on JGBO »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
-
Jiangbo Predicts Quick Ramp-Up of Hypertension Drug SalesChinaBio Today • Wed, Aug 18, 2010
-
-
'Goldman Friday' Demonstrates Volatility of Chinese Small CapsChina OTC Player • Mon, Apr 19, 2010
-
-
-
-
-
-
-
-
China Biotech Week in Review: China Life Science ConvergenceChinaBio Today • Mon, Jan 18, 2010
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
Jiangbo Predicts Quick Ramp-Up of Hypertension Drug SalesChinaBio Today • Wed, Aug 18, 2010
-
-
-
-
-
-
Genesis Pharma Reports Improved Q1ChinaBio Today • Tue, Nov 18, 2008
-
Genesis Pharma Books 31% Higher Revenues in 2008ChinaBio Today • Thu, Oct 2, 2008
-
Genesis Announces $12 Million in New OrdersChinaBio Today • Sun, Sep 14, 2008
-
Genesis Pharma Completes 40-to-1 Reverse SplitChinaBio Today • Fri, Sep 5, 2008
-
-
-
-
-
-
-
-
'Goldman Friday' Demonstrates Volatility of Chinese Small CapsChina OTC Player • Mon, Apr 19, 2010
-
-
-
-
-
-
-
China Biotech Week in Review: China Life Science ConvergenceChinaBio Today • Mon, Jan 18, 2010
-
-
China Biotech in Review: Investments ContinueChinaBio Today • Sun, Feb 22, 2009
-
-
China Biopharma News Back in the SpotlightChinaBio Today • Sun, Nov 23, 2008
-
China Biotech in Review: Deals and EarningsChinaBio Today • Sun, Oct 5, 2008
There are no News articles on JGBO.
JGBO vs. ETF Alternatives
Company Description
Jiangbo Pharmaceuticals, Inc. is a holding company incorporated in Florida with its principal place of business in the People’s Republic of China (the “PRC”). We operate, control and beneficially own the pharmaceutical business of Laiyang Jiangbo. Laiyang Jiangbo researches, develops,... More
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.